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Abstract 
BACKGROUND: Caudal block remains fundamental in pediatric anaesthetic practice. It is very useful in a wide 
range of surgical procedures and has proved to have a remarkable safety record, But one of the major limitations 
of the single-injection technique is the relatively short duration of postoperative analgesia. Prolongation of caudal 
analgesia using single-shot technique has been achieved by the addition of various adjuvant. 
AIM: This work aims to compare magnesium and dexmedetomidine as adjuvants to bupivacaine-induced caudal 
block in children undergoing lower limb orthopaedic surgery. 
STUDY DESIGN: Randomized, double-blind trial. 
SETTINGS: Pediatric or of a tertiary care centre. 
METHODS: A double-blinded, randomised controlled trial included 36 children, aged between 1 and 7 years, 
scheduled for lower limb orthopaedic surgery. Patients received general anaesthesia in addition to the caudal 
block. Patients were divided into three groups: Dexmedetomidine group (n = 12): received 0.5 mL/Kg bupivacaine 
+ 2 mcg/Kg dexmedetomidine, Magnesium group (n = 12): received 0.5 mL/Kg bupivacaine + 50 mg magnesium, 
and control group (n = 12): received 0.5 mL/Kg bupivacaine + normal saline. Patients were compared according 
to the duration of analgesia, pain scores, sedation scores, mean arterial pressure, and heart rate. 
RESULTS: Both magnesium group and dexmedetomidine group showed better analgesic profile (duration of 
analgesia and pain scores) compared to the control group without significant difference between the two former 
groups. Dexmedetomidine group showed higher sedation score, lower mean arterial pressure and lower heart 
rate compared to other groups. 
CONCLUSIONS: Both magnesium (50 mg) and dexmedetomidine (2 mcg/Kg) improved the analgesic profile of 
bupivacaine-induced caudal block in children. Dexmedetomidine administration was accompanied with higher 
sedation score and negative hemodynamic profile. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Caudal block remains fundamental in 
pediatric anaesthetic practice. Single-injection 
technique for the caudal block is usually limited by 
short duration of postoperative analgesia [1]. Addition 
of adjuvants to local anaesthetics could prolong the 
duration of the caudal block.  
Dexmedetomidine (Dex) is a highly selective 
α2-adrenoreceptor agonist with various uses in 
anaesthesia and intensive care units [2], [3]. Dex 
offers a unique pharmacological profile because it is a 
sedative, sympatholytic, analgesic with minimal 
respiratory depression. Dex had shown good results 
when used as an adjuvant to caudal block [4]. 
Although dexmedetomidine is a highly promising 
adjuvant to local anaesthetics, its use is limited by the 
negative hemodynamic profile and the high cost.  
Magnesium (Mg) is another drug which has 
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analgesic and antinociceptive effects. In a recent 
systematic review, Kawakami et al. had reported that 
Mg improved the analgesic profile of caudal block in 
children [5]. To the best of our knowledge, no data is 
available for comparison of Dex and Mg as adjuvants 
to bupivacaine-induced caudal block in children. 
We conducted this study to compare the 
analgesic and hemodynamic effects of 
dexmedetomidine and magnesium sulphate when 
added to bupivacaine in the caudal block in children.  
 
 
Methods 
 
This double-blinded, randomised, controlled 
trial was conducted in Cairo University hospital after 
approval of the research ethics committee. Written 
informed consent was obtained from the patient’s 
parents or guardians. 
Thirty-six patients aged between 1-7 years, 
ASA I-II scheduled for infra-umbilical orthopaedic 
surgeries were included in the study. Patients were 
randomly assigned into 3 groups using an online 
randomisation program (http://www.randomizer.org). 
Concealment was achieved using opaque envelopes. 
Exclusion criteria include allergy to the study drugs, 
suspected coagulopathy, local infection, history of 
developmental delay, neuromuscular disorders, 
skeletal deformities, and magnesium therapy, Patients 
in whom caudal block failed were excluded from our 
study.  
On arrival to the preparing room, patients 
were sedated by midazolam (0.2 mg/kg IM).On arrival 
to the operating room, patients were monitored using 
five-lead electrocardiography (ECG), automated non-
invasive blood pressure monitor (NIBP), pulse 
oximetry and temperature probe. 
Inhalational induction of anaesthesia was 
achieved by sevoflurane in 100% oxygen, and an 
appropriate-sized cannula was inserted. The 
endotracheal tube was inserted. 
Patients were randomly assigned into 3 
groups: 
a. Group D (n = 12): received caudal block 
bupivacaine (0.25%) at dose of 1 mL/Kg plus 
dexmetedomidine (2 μg/kg diluted into 0.5 mL) mL/Kg.  
b. Group M (n = 12): received caudal block 
with bupivacaine (0.25%) at a dose of 1 mL/Kg plus 
magnesium sulphate (50 mg in 0.5 mL) 
c. Group C (n = 12): received caudal block 
withbupivacaine 0.25% diluted in normal saline at a 
dose of 1 ml/kg plus 0.5 mL normal saline. 
At the end of the operation, sevoflurane was 
discontinued. The endotracheal tube was removed, 
and patients were discharged in the post-anesthesia 
care unit. Rescue analgesia in the form of oral 
paracetamol (10-15 mg/kg/dose) was taken and had 
to be repeated every 6 hours if needed (the time at 
which FLACC score 4 or more). 
The patients were transferred to the ward 
after spending two hours in the recovery room after 
the surgery. 
Duration of analgesia (defined as the time of 
caudal block was performed to the time at which 
FLACC score 4 or more) 
Hemodynamic measures: mean arterial blood 
pressure (MAP) (mmHg) and heart rate (bpm): were 
measured at the baseline (before induction of 
anaesthesia), after induction of anaesthesia, and 
every 5 minutes till the end of the operation. We 
analysed three readings: baseline reading, post-
caudal block reading, and the average of all other 
intra-operative readings. 
Pain score (FLACC score) [6] ( ranging from 0 
to10): was assessed at the end of surgery and 1, 2, 6, 
8, and 12 hours postoperatively,  
Ramsay score [7]: (ranging from 1 to 8 )was 
recorded after PACU arrival  
Total (12-hours) postoperative paracetamol 
requirements were recorded 
Complications secondary to test drugs 
(postoperative nausea, vomiting, bradycardia (HR < 
80 BPM) and hypotension (SBP < 70 mmHg+ age in 
years * 2) were also reported. 
Our primary outcome was the duration of 
analgesia. The previous study showed a mean 
duration of analgesia286.4 ± 47.8 minutes in children 
who received bupivacaine in caudal block [8]. We 
calculated our sample size to detect a difference of 
20% (58 ± 47.8 minutes) between study groups. A 
minimum number of 9 patients per group were 
calculated to have a study power of 80% and an alpha 
error of 0.05. The number was increased to 12 
patients per group to compensate for dropouts. 
Data were statistically described regarding 
mean ± standard deviation (± SD), median and range, 
or frequencies (number of cases) and percentages as 
deemed appropriate. Comparison of numerical 
variables was made using one-way analysis of 
variance (ANOVA) test with post-hoc multiple 2-group 
comparisons in normally distributed data, and Kruskal-
Wallis test with post-hoc multiple 2-group 
comparisons in skewed data. For comparing 
categorical data, Chi-square (
2
) test was performed. 
The exact test was used instead when the expected 
frequency is less than 5. A p value less than 0.05 was 
considered statistically significant. All statistical 
calculations were done using computer program 
SPSS (Statistical Package for the Social Science; 
SPSS Inc., Chicago, IL, USA) release 15 for Microsoft 
Windows (2006). 
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Results 
 
Forty-four patients were screened for 
eligibility. Six patients were excluded, and 36 patients 
were available for final analysis (Figure 1).  
 
Figure 1: Consort chart for patient enrolment 
 
Demographic data were comparable between 
the three groups (Table 1). 
Table 1: Patient characteristics. Data are presented as mean ± 
standard deviation and frequency (%) 
 Group C (n = 12) Group D (n = 12) Group M (n = 12) 
Age (years) 4.11 ± 1.7 3.9 ± 2.2 3.1 ± 1.4 
Weight (kg) 17.3 ± 4.1 16.8 ± 4.9 15.2 ± 4.1 
Male gender 8 (67%) 6 (50%) 3 (25%) 
Data are presented as mean ± standard deviation and frequency (%). 
 
FLACC score was lower in both Group M and 
Group D when compared to Group C at all 
postoperative readings (Table 2).  
Table 2: Mean arterial pressure. Data are presented as mean ± 
standard deviation 
 Group C (n = 12) Group D (n = 12) Group M (n = 12) 
Baseline reading (mmHg) 70 ± 11 63 ± 9 63 ± 10 
Post-block reading (mmHg) 63 ± 8 55 ± 9 66 ± 8 
Mean intraoperative reading 
(mmHg) 
60 ± 15 48 ± 6* 52 ± 7 
*denotes significance compared to group C. 
 
Group D showed lower FLACC score 
compared to group M at the first postoperative hour; 
while both groups were comparable in the subsequent 
readings (Table 3).  
 
Table 3: Heart rate. Data are presented as a mean ± standard 
deviation 
 Group C (n = 
12) 
Group D (n = 12) Group M (n = 
12) 
Baseline reading (mmHg) 136 ± 13 136 ± 20 138 ± 16 
Post-block reading (mmHg) 124 ± 11 118 ± 10 119 ± 13 
Mean intraoperative reading 
(mmHg) 
115 ± 13 103 ± 7 * 111 ± 10 
*denotes significance compared to group C. 
 
Ramsay score was comparable between 
group D and group M; while it was higher in both 
groups compared to group C (Table 4). 
Table 4: FLACC score. Data are presented as median (range) 
 Group C (n = 12) Group D (n = 12) Group M (n = 12) 
One-hour postoperative 1.5 (1-3) *0 (0-1) *1 (0-2) 
Two-hour postoperative 2 (2-4) *1 (0-2) *2 (1-2) 
Six-hour postoperative 4 (2-6) *2 (0-4) *2 (1-4) 
Eight-hour postoperative 5 (4-6) *4 (1-5) *4 (2-6) 
Twelve-hour postoperative 6 (5-6) *4 (4-4) *4 (4-6) 
FLACC: face, legs, activity, cry, insolubility scale; *denotes significance compared to group 
C; † denotes significance compared to group M. 
 
Time of 1
st 
rescue analgesia was longer in the 
group M, and group D compared to group C without 
significant difference between the two former groups 
(7.83 ± 1.19 hours, 7.75 ± 1.35 hours, and 4.92 ± 1.16 
respectively) (Table 5). 
Table 5: Postoperative data. Data are presented as mean ± 
standard deviation, median (range), and frequency (%) 
 Group C (n = 
12) 
Group D (n = 12) Group M (n = 
12) 
Ramsay score 2 (2-2) 4 (4-5) *† 4 (2-5) * 
Time to rescue analgesia (hours) 4.9 ± 1.2 7.8 ± 1.4 * 7.8 ± 1.2 * 
Number of rescue analgesic 
boluses (1 bolus / 2 boluses) 
4/8 12/0 * 12/0 * 
*denotes significance compared to group C. † denotes significance compared to group M. 
 
Hemodynamic measures (MAP and heart 
rate) were comparable between the three groups at 
the baseline and post-block reading. Post-hoc 
analysis showed no difference between Group M and 
the other two groups in the intraoperative 
hemodynamic readings; while Group D had lower 
mean intraoperative readings compared to group C 
(MAP: 60.33 ± 14.9 vs 47.58 ± 5.6, p = 0.029), and 
(114.83 ± 13.5 vs 102.92 ± 7.2, p = 0.012)(Table 2 
and 3). 
 
 
Discussion 
 
We reported that both dexmedetomidine and 
magnesium improved the analgesic properties of the 
caudal block when added to bupivacaine. No 
difference was observed between both drugs 
according to the duration of analgesia and pain score 
at most of the postoperative reading; however, 
dexmedetomidine was associated with lower 
intraoperative MAP and heart rate. Dexmedetomidine 
had been frequently reported as one of the most 
promising additives in neuraxial as well as peripheral 
nerve blocks [2], [9]. In a recent review, Trifa et al. had 
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suggested that there is sufficient evidence to 
recommend adding dexmedetomidine to local 
anaesthetics in the caudal block in children [4]. 
Dexmedetomidine is an alpha-2 adrenoreceptor 
agonist with unique pharmacological properties overall 
response to α2 adrenoreceptors agonists is related to 
the stimulation of α2 adrenoreceptors located in the 
CNS and spinal cord. These receptors are involved in 
the sympatholysis, sedation, and antinociception 
effects of α2 adrenoreceptors [10]. Although 
dexmedetomidine is a potent adjuvant to local 
anaesthetics, its use had some limitations such as 
high cost and negative hemodynamic profile.  
Magnesium is another drug with various 
clinical uses. Magnesium is a non-competitive NMDA 
receptor antagonist that promotes intracellular 
signalling culminating in long-term synaptic plasticity 
and the ‘wind-up’ phenomenon. Blocking the channel 
inhibits the development and maintenance of central 
sensitisation [5]. Thus, magnesium is characterised by 
useful analgesic effects when used as an adjuvant to 
local anaesthetics. In a recent systematic review and 
meta-analysis, Kawakami et al. had [5)] reported that 
magnesium might improve the analgesic properties of 
the ropivacaine-induced caudal block in children. 
Kawakami et al. had [5] recommended more 
randomised controlled trials to affirm their findings. No 
study to the best of our knowledge had investigated 
magnesium as an adjuvant to bupivacaine in the 
caudal block in children. We reported that using 
dexmedetomidine was associated with negative 
cardiovascular profile compared to magnesium; this 
finding is in line with most of the available data for 
using dexmedetomidine in neuraxial and peripheral 
nerve blocks [3], [9], [11]. Systemic absorption of 
dexmedetomidine had been well reported after extra-
vascular injection [12]. This systemic absorption is 
associated with linear dose-dependent plasma level 
[13]. 
Pain management in children is essential and 
challenging. Caudal analgesia is the commonest 
regional block performed in the pediatric population. 
To the best of our knowledge, this is the first trial 
which compares magnesium and dexmedetomidine in 
the caudal block. It is also the first study to investigate 
both drugs as adjuvants to bupivacaine. Our findings 
suggest that the use of both magnesium and 
dexmedetomidine was associated with similar 
analgesic properties. This favours the use magnesium 
as a reasonable choice in the caudal block which is 
efficient, economic, and safe. 
Our study has the advantage of being a well-
powered, double-blinded, randomized controlled trial. 
However, it had some limitations: 1- It is a single 
centre study. 2- We used a single dose for each drug. 
3- We performed as a single shot caudal block; thus, 
we could not extrapolate our findings in continuous 
blocks. We recommend future studies to evaluate the 
optimum doses and to investigate both drugs in 
continuous blocks. 
In conclusion, both magnesium (50 mg) and 
dexmedetomidine (2 mcg/Kg) improved the analgesic 
profile of bupivacaine-induced caudal block in 
children. Dexmedetomidine administration was 
accompanied with higher sedation score and negative 
hemodynamic profile. 
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